Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People With Parkinson's Disease
November 17, 2021
November 17, 2021
NEW HAVEN, Connecticut, Nov. 17 (TNSGra) -- Yale School of Medicine issued the following news:
Two Yale Department of Psychiatry researchers have been awarded a $2 million grant from The Michael J. Fox Foundation for Parkinson's Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson's disease.
Sophie E. Holmes, PhD, Assistant Professor of Psychiatry and Neurology, and Gerard Sanacora, MD, PhD, George D. and Esther . . .
Two Yale Department of Psychiatry researchers have been awarded a $2 million grant from The Michael J. Fox Foundation for Parkinson's Research to conduct the first clinical trial of ketamine to treat depression in people with Parkinson's disease.
Sophie E. Holmes, PhD, Assistant Professor of Psychiatry and Neurology, and Gerard Sanacora, MD, PhD, George D. and Esther . . .